skip to main content
US FlagAn official website of the United States government
dot gov icon
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
https lock icon
Secure .gov websites use HTTPS
A lock ( lock ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Explore Research Products in the PAR
It may take a few hours for recently added research products to appear in PAR search results.


  • Home
  • Search Results
  • Page 1 of 1

Search for: All records

Creators/Authors contains: "Gohar, Azeem"

Note: When clicking on a Digital Object Identifier (DOI) number, you will be taken to an external site maintained by the publisher. Some full text articles may not yet be available without a charge during the embargo (administrative interval).
What is a DOI Number?

Some links on this page may take you to non-federal websites. Their policies may differ from this site.

  1. (, International Supply Chain Technology Journal)
    Ever since the beginning of COVID-19 Pandemic, researchers from across the world have been investigating different options for the treatment of SARS-COV-2. This is critical even after two years from the start of pandemic due to different variants resulting in new waves of this virus spreading globally. In this regard, December 22 and 23rd, 2021 are landmark days, when FDA granted authorization to Pfizer’s Paxlovid and Merck’s Molnupiravir (COVID-19 Oral Antiviral products) for emergency use (EUA). The director of the FDA’s Center for Drug Evaluation and Research Patrizia Cavazzoni, M.D., described this an enormous step to tackle this global pandemic 
    more » « less
    Full Text Available